CeriBell Valuation
| CBLL Stock | 20.61 0.18 0.88% |
At this time, the firm appears to be undervalued. CeriBell shows a prevailing Real Value of USD25.22 per share. The current price of the firm is USD20.61. Our model approximates the value of CeriBell from analyzing the firm fundamentals such as Return On Equity of -0.6, profit margin of (0.63) %, and Current Valuation of 610.67 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CeriBell's valuation include:
Undervalued
Today
Please note that CeriBell's price fluctuation is not too volatile at this time. Calculation of the real value of CeriBell is based on 3 months time horizon. Increasing CeriBell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CeriBell stock is determined by what a typical buyer is willing to pay for full or partial control of CeriBell. Since CeriBell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CeriBell Stock. However, CeriBell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.61 | Real 25.22 | Target 28.14 | Hype 19.97 | Naive 19.06 |
The intrinsic value of CeriBell's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CeriBell's stock price.
Estimating the potential upside or downside of CeriBell helps investors to forecast how CeriBell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CeriBell more accurately as focusing exclusively on CeriBell's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CeriBell's intrinsic value based on its ongoing forecasts of CeriBell's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CeriBell's closest peers.
CeriBell Cash |
|
CeriBell Revenue by Product
CeriBell Total Value Analysis
CeriBell is currently expected to have valuation of 610.67 M with market capitalization of 764.54 M, debt of 21.96 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CeriBell fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
610.67 M | 764.54 M | 21.96 M |
CeriBell Investor Information
About 82.0% of the company shares are held by institutions such as insurance companies. The book value of CeriBell was currently reported as 4.43. The company recorded a loss per share of 3.67. CeriBell had not issued any dividends in recent years. CeriBell is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.CeriBell Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CeriBell has an asset utilization ratio of 29.03 percent. This suggests that the Company is making USD0.29 for each dollar of assets. An increasing asset utilization means that CeriBell is more efficient with each dollar of assets it utilizes for everyday operations.CeriBell Profitability Analysis
Taking into consideration CeriBell's profitability measurements, CeriBell may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess CeriBell's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -36.4 M | Current Value -38.2 M | Quarterly Volatility 2.1 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.68 | 0.78 |
|
|
For CeriBell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CeriBell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CeriBell utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CeriBell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CeriBell over time as well as its relative position and ranking within its peers.
CeriBell Earnings per Share Projection vs Actual
The next projected EPS of CeriBell is estimated to be -0.3767 with future projections ranging from a low of -0.44 to a high of -0.33. CeriBell's most recent 12-month trailing earnings per share (EPS TTM) is at -3.67. Please be aware that the consensus of earnings estimates for CeriBell is based on EPS before non-recurring items and includes expenses related to employee stock options.CeriBell Earnings Estimation Breakdown
The calculation of CeriBell's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CeriBell is estimated to be -0.3767 with the future projection ranging from a low of -0.44 to a high of -0.33. Please be aware that this consensus of annual earnings estimates for CeriBell is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.44 Lowest | Expected EPS | -0.33 Highest |
CeriBell Earnings Projection Consensus
Suppose the current estimates of CeriBell's value are higher than the current market price of the CeriBell stock. In this case, investors may conclude that CeriBell is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CeriBell's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 8 | 50.0% | 0.0 | -0.3767 | -3.67 |
CeriBell Ownership Allocation
CeriBell holds a total of 37.1 Million outstanding shares. The majority of CeriBell outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CeriBell to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in CeriBell. Please pay attention to any change in the institutional holdings of CeriBell as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CeriBell Profitability Analysis
The company reported the previous year's revenue of 65.44 M. Net Loss for the year was (40.45 M) with profit before overhead, payroll, taxes, and interest of 72.87 M.About CeriBell Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CeriBell. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CeriBell based exclusively on its fundamental and basic technical indicators. By analyzing CeriBell's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CeriBell's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CeriBell. We calculate exposure to CeriBell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CeriBell's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 65.3 M | 42.7 M | |
| Pretax Profit Margin | (0.56) | (0.58) | |
| Operating Profit Margin | (0.55) | (0.57) | |
| Net Loss | (0.56) | (0.58) | |
| Gross Profit Margin | 0.78 | 0.68 |
CeriBell Current Valuation Indicators
CeriBell's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final CeriBell's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CeriBell, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CeriBell's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CeriBell's worth.When determining whether CeriBell is a strong investment it is important to analyze CeriBell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CeriBell's future performance. For an informed investment choice regarding CeriBell Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CeriBell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. Projected growth potential of CeriBell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CeriBell assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CeriBell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CeriBell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CeriBell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.